Sharavan Ramachandran

1.2k total citations · 1 hit paper
20 papers, 847 citations indexed

About

Sharavan Ramachandran is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Sharavan Ramachandran has authored 20 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Sharavan Ramachandran's work include Cancer, Hypoxia, and Metabolism (3 papers), Autophagy in Disease and Therapy (3 papers) and FOXO transcription factor regulation (3 papers). Sharavan Ramachandran is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Autophagy in Disease and Therapy (3 papers) and FOXO transcription factor regulation (3 papers). Sharavan Ramachandran collaborates with scholars based in United States, India and United Kingdom. Sharavan Ramachandran's co-authors include Sanjay Srivastava, Itishree Kaushik, Sangeeta Srivastava, Sahdeo Prasad, Nehal Gupta, Suyash Srivastava, Shiva Sivasubramaniam, Alok Ranjan, Stephen E. Wright and Hiranmoy Das and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Sharavan Ramachandran

20 papers receiving 837 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of Phytochemicals in Cancer Prevention

2019 261 citations Alok Ranjan, Sharavan Ramachandran et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharavan Ramachandran United States	11	465	209	152	113	90	20	847
Bilal Rah India	20	653 1.4×	238 1.1×	199 1.3×	125 1.1×	122 1.4×	47	1.2k
Giuseppa Augello Italy	21	529 1.1×	165 0.8×	192 1.3×	107 0.9×	84 0.9×	35	1.0k
Sheryl Phung United States	20	530 1.1×	269 1.3×	197 1.3×	129 1.1×	85 0.9×	32	1.2k
Aranka Brockmueller Germany	19	530 1.1×	163 0.8×	206 1.4×	125 1.1×	72 0.8×	33	1.1k
Alok Ranjan United States	18	610 1.3×	242 1.2×	221 1.5×	70 0.6×	106 1.2×	38	1.1k
Lingtao Jin United States	10	452 1.0×	123 0.6×	192 1.3×	144 1.3×	67 0.7×	14	869
Nehal Gupta United States	12	479 1.0×	168 0.8×	152 1.0×	67 0.6×	101 1.1×	18	836
Tanveer Sharif Canada	22	645 1.4×	276 1.3×	205 1.3×	104 0.9×	39 0.4×	35	1.2k
Anna Galkin United States	15	493 1.1×	252 1.2×	119 0.8×	161 1.4×	228 2.5×	28	1.1k
Roopesh Krishnankutty Qatar	15	445 1.0×	239 1.1×	174 1.1×	125 1.1×	78 0.9×	33	820

Countries citing papers authored by Sharavan Ramachandran

Since Specialization

Citations

This map shows the geographic impact of Sharavan Ramachandran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharavan Ramachandran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharavan Ramachandran more than expected).

Fields of papers citing papers by Sharavan Ramachandran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharavan Ramachandran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharavan Ramachandran. The network helps show where Sharavan Ramachandran may publish in the future.

Co-authorship network of co-authors of Sharavan Ramachandran

This figure shows the co-authorship network connecting the top 25 collaborators of Sharavan Ramachandran. A scholar is included among the top collaborators of Sharavan Ramachandran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharavan Ramachandran. Sharavan Ramachandran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramachandran, Sharavan, et al.. (2023). Abstract 4873: Pimavanserin suppresses glioblastoma progression by modulating the Akt/FOXO/Bim signaling axis. Cancer Research. 83(7_Supplement). 4873–4873. 1 indexed citations

Kaushik, Itishree, et al.. (2022). Immune checkpoint proteins: Signaling mechanisms and molecular interactions in cancer immunotherapy. Seminars in Cancer Biology. 86(Pt 3). 137–150. 101 indexed citations

Ramachandran, Sharavan, et al.. (2022). Abstract 1559: Repurposing of pimavanserin tartrate for the treatment of glioblastoma. Cancer Research. 82(12_Supplement). 1559–1559. 1 indexed citations

Ramachandran, Sharavan, et al.. (2022). Abstract 3896: Pimavanserin suppresses the growth of medulloblastoma by inhibiting Lyn/STAT3/MBSC signaling axis. Cancer Research. 82(12_Supplement). 3896–3896. 2 indexed citations

Kaushik, Itishree, et al.. (2022). The evolutionary legacy of immune checkpoint inhibitors. Seminars in Cancer Biology. 86(Pt 2). 491–498. 52 indexed citations

Ramachandran, Sharavan & Sanjay Srivastava. (2021). Abstract LB184: Induction of ulk1 regulated autophagy by a novel antipsychotic drug leads to apoptosis in pancreatic cancer cells. Cancer Research. 81(13_Supplement). LB184–LB184. 1 indexed citations

Ramachandran, Sharavan, Itishree Kaushik, & Sanjay Srivastava. (2021). Pimavanserin: A Novel Autophagy Modulator for Pancreatic Cancer Treatment. Cancers. 13(22). 5661–5661. 10 indexed citations

Ramachandran, Sharavan & Sanjay Srivastava. (2020). Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy. Molecular Therapy — Oncolytics. 19. 19–32. 15 indexed citations

Kaushik, Itishree, Sharavan Ramachandran, Sahdeo Prasad, & Sanjay Srivastava. (2020). Drug rechanneling: A novel paradigm for cancer treatment. Seminars in Cancer Biology. 68. 279–290. 42 indexed citations

10.

Ramachandran, Sharavan, et al.. (2020). Retrospective Analysis of Plagiaristic Practices within a Cinematic Industry in India – a Tip in the Ocean of Icebergs. Journal of Academic Ethics. 18(2). 143–153. 2 indexed citations

11.

Ramachandran, Sharavan & Sanjay Srivastava. (2020). Abstract 1218: Pimavanserin induces autophagy mediated apoptosis in pancreatic cancer and suppresses pancreatic tumor growth. Cancer Research. 80(16_Supplement). 1218–1218. 1 indexed citations

12.

Ranjan, Alok, Sharavan Ramachandran, Nehal Gupta, et al.. (2019). Role of Phytochemicals in Cancer Prevention. International Journal of Molecular Sciences. 20(20). 4981–4981. 261 indexed citations breakdown →

13.

Kaushik, Itishree, Sharavan Ramachandran, & Sanjay Srivastava. (2019). CRISPR-Cas9: A multifaceted therapeutic strategy for cancer treatment. Seminars in Cell and Developmental Biology. 96. 4–12. 19 indexed citations

14.

Prasad, Sahdeo, Sharavan Ramachandran, Nehal Gupta, Itishree Kaushik, & Sanjay Srivastava. (2019). Cancer cells stemness: A doorstep to targeted therapy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(4). 165424–165424. 114 indexed citations

15.

Kim, Chang-Geun, Hyemin Lee, Nehal Gupta, et al.. (2017). Role of Forkhead Box Class O proteins in cancer progression and metastasis. Seminars in Cancer Biology. 50. 142–151. 88 indexed citations

16.

Ramachandran, Sharavan & Sanjay Srivastava. (2017). Abstract 4422: Capsaicin suppresses pancreatic tumor growth by inhibiting tumor cell metabolism. Cancer Research. 77(13_Supplement). 4422–4422. 2 indexed citations

17.

Fofaria, Neel M., Sharavan Ramachandran, & Sanjay Srivastava. (2017). Therapeutic Potential of Black Pepper Compound for BRaf Resistant Melanoma. SHILAP Revista de lepidopterología. 981–981. 3 indexed citations

18.

Sathe, Gajanan, Anil K. Madugundu, Sharavan Ramachandran, et al.. (2016). Proteomic profiling of retinoblastoma by high resolution mass spectrometry. Clinical Proteomics. 13(1). 29–29. 29 indexed citations

19.

Sivasubramaniam, Shiva, et al.. (2016). A close encounter with ghost-writers: an initial exploration study on background, strategies and attitudes of independent essay providers. International Journal for Educational Integrity. 12(1). 32 indexed citations

20.

Deepak, Venkataraman, Sharavan Ramachandran, Sureshbabu Ram Kumar Pandian, et al.. (2015). In vitro evaluation of anticancer properties of exopolysaccharides from Lactobacillus acidophilus in colon cancer cell lines. In Vitro Cellular & Developmental Biology - Animal. 52(2). 163–173. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact